Revolutionizing the Management of CKD in Patients with T2D

Speakers

Dr. Mohammad J. Mairza

Dr. Mohammad J. Mairza

Consultant - Internal Medicine

Qualifications:
• Membership of The Royal College of Physicians (MRCP-UK) London
• Kuwaiti Board of Internal Medicine (SCIM-KIMS)
• SCOPE Certificate in Obesity and Weight Management
• Bachelor of Medicine, Surgery and Obstetrics (MB, BCh, BAO) University College Cork-Ireland
• Secondment in the Internal Medicine Department - Faculty of Medicine, Kuwait University
• Clinical tutor in the Kuwaiti Board of Internal Medicine

Specialized in:
• Diagnosis and treatment of chronic medical conditions such as diabetes, high blood pressure, and blood-related diseases.
• Treatment of acute diseases such as fever, influenza, rhinosinusitis, headache, and infections of the throat, chest, and digestive system.
• Gastroesophageal reflux disease and irritable bowel syndrome.
• Treatment and management of iron deficiency, vitamin deficiencies, and osteoporosis.
• General health and cancer screening.
• Breast examination and cancer screening.
• Obesity and nutritional counseling.

03 September 2026

12:00 - 13:00

Objectives:    
• To emphasize the importance of SGLT2 inhibitors in the management of patients with CKD and Type 2 Diabetes.
• Implement evidence-based approaches to slow CKD progression and reduce cardiovascular risk in patients with T2D and CKD, including optimization of blood pressure, glycemic control, renin-angiotensin system blockade, and lifestyle measures.